The Business Research Company’s Oncolytic Virus Therapy Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Oncolytic Virus Therapy Global Market Report 2023 evaluates oncolytic virus therapy market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12391&type=smp
The global oncolytic virus therapy market is expected to grow from $0.12 billion in 2022 to $0.15 billion in 2023 at a compound annual growth rate (CAGR) of 26.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The oncolytic virus therapy market is expected to reach $0.36 billion in 2027 at a CAGR of 24.6%.
The increasing prevalence of cancer cases is expected to propel the growth of the oncolytic virus therapy market going forward. Cancer is a term used to describe a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Oncolytic virus therapy offers the potential to selectively target and destroy cancer cells while stimulating an immune response against the tumor, providing a dual mechanism of action for effective cancer treatment. For instance, in 2020, according to Globocan, a Switzerland-based provider of a worldwide database of cancer incidence and mortality rates, there were around 19.29 million new cancer cases, and the number of cancer cases in 5 years is estimated to be 50.55 million. Therefore, the increasing prevalence of cancer cases will drive the future oncolytic virus therapy market.
Get More Information On The Oncolytic Virus Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/oncolytic-virus-therapy-global-market-report
The oncolytic virus therapy market segments in the report are:
1) By Therapy Type: HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types
2) By Virus Type: Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses
3) By Application: Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer
4) By End-User: Hospitals, Specialty Clinics, Cancer Research Institutes
The table of contents in TBRC’s oncolytic virus therapy market report includes:
- Executive Summary
- Oncolytic Virus Therapy Market Characteristics
- Oncolytic Virus Therapy Market Trends And Strategies
- Oncolytic Virus Therapy Market – Macro Economic Scenario
- Oncolytic Virus Therapy Market Segmentation.
.
.
- Global Oncolytic Virus Therapy Market Competitive Benchmarking
- Global Oncolytic Virus Therapy Market Competitive Dashboard
- Key Mergers And Acquisitions In The Oncolytic Virus Therapy Market
- Oncolytic Virus Therapy Market Future Outlook and Potential Analysis
- Appendix
Top Major Players:
- Pfizer Inc.
- Johnson & Johnson
- Sorrento Therapeutics Inc.
- AbbVie Inc.
- AstraZeneca plc
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
